GSK begins its first trial of adjuvanted pandemic flu vaccine
This article was originally published in Scrip
Executive Summary
GlaxoSmithKline has completed enrolment for the first clinical trial of its adjuvant pandemic (H1N1) 2009 influenza vaccine.